Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECOS: Ibuprofen Dosage Efficacy in Third Molar Surgery
NCT05126264Completed
- Sponsor
- Complutense University of Madrid
- Start
- Dec 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ibuprofen in postoperative pain and inflammation (2 arms), sponsored by Complutense University of Madrid. Primary endpoint: Post operative Pain at 7 days. Started Dec 2021; status: completed.
02
Drugs
ibuprofen
03
Conditions
postoperative paininflammation
Beyond the preview
Go deeper on NCT05126264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05126264.